These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 8476217)
1. Growth inhibitory substances in human breast cyst fluid. Lai LC; Chan CT; Cornell C; Lennard TW Anticancer Res; 1993; 13(1):225-7. PubMed ID: 8476217 [TBL] [Abstract][Full Text] [Related]
2. Oestradiol and epidermal growth factor in breast cyst fluid. Lai LC; Dunkley SA; Reed MJ; Ghilchik MW; James VH Anticancer Res; 1989; 9(6):1853-6. PubMed ID: 2627131 [TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor in breast cyst fluid: relationship with intracystic cation and androgen conjugate content. Boccardo F; Valenti G; Zanardi S; Cerruti G; Fassio T; Bruzzi P; De Franchis V; Barreca A; Del Monte P; Minuto F Cancer Res; 1988 Oct; 48(20):5860-3. PubMed ID: 2971432 [TBL] [Abstract][Full Text] [Related]
4. Tumour necrosis factor-alpha and interleukin-1 and -6 in fibrocystic breast disease. Herruzo A; Castilla JA; Ramírez A; Marcos C; Menjón S Breast Cancer Res Treat; 1999 Mar; 54(2):159-64. PubMed ID: 10424406 [TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor alpha, beta 1 and beta 2 in breast cyst fluid. Lai LC; Siraj AK; Erbas H; Lennard TW Anticancer Res; 1994; 14(6B):2805-9. PubMed ID: 7872722 [TBL] [Abstract][Full Text] [Related]
6. Oncostatin M, interleukin 2, interleukin 6 and interleukin 8 in breast cyst fluid. Lai LC; Kadory S; Siraj AK; Lennard TW Int J Cancer; 1994 Nov; 59(3):369-72. PubMed ID: 7927943 [TBL] [Abstract][Full Text] [Related]
7. Association of cyst type with risk factors for breast cancer and relapse rate in women with gross cystic disease of the breast. Naldoni C; Costantini M; Dogliotti L; Bruzzi P; Bucchi L; Buzzi G; Torta M; Angeli A Cancer Res; 1992 Apr; 52(7):1791-5. PubMed ID: 1551110 [TBL] [Abstract][Full Text] [Related]
8. Relationships between oestrogen-inducible proteins, oestradiol and electrolyte ratio in breast cyst fluid. Lai LC; Cornell C; Lennard TW Cancer Lett; 1993 Apr; 69(1):21-5. PubMed ID: 8481890 [TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor and oestradiol in human breast cyst fluid. Lai LC; Dunkley SA; Reed MJ; Ghilchik MW; Shaikh NA; James VH Eur J Cancer; 1990 Apr; 26(4):481-4. PubMed ID: 2141515 [TBL] [Abstract][Full Text] [Related]
10. Biochemical analysis of breast cyst fluid as a possible predictor of breast carcinoma development. Simíøcková M; Pecen L; Eben K; Nekulová M; Vermousek I; Stratil P; Rejthar A; Cernoch M; Lang B; Sakalová J Neoplasma; 1994; 41(5):245-52. PubMed ID: 7854493 [TBL] [Abstract][Full Text] [Related]
11. Presence of epidermal growth factor receptor in breast smears of cyst fluids: relationship to electrolyte ratios and pH concentration. Athanassiadou PP; Veneti SZ; Kyrkou KA; Intzes KS; Mouzaka LI; Papadimitriou GK Cancer Detect Prev; 1992; 16(2):113-8. PubMed ID: 1600520 [TBL] [Abstract][Full Text] [Related]
12. Presence of immunoassayable transforming growth factor-beta 1 (TGF-beta 1) in breast cyst fluid (BCF): relationship with the intracystic electrolyte and epidermal-growth-factor (EGF) content. Zanardi S; Pensa F; Torrisi R; De Franchis V; Barreca A; Minuto F; Boccardo F Int J Cancer; 1994 Dec; 59(6):725-7. PubMed ID: 7989108 [TBL] [Abstract][Full Text] [Related]
13. Latent forms of transforming growth factor-beta 2 (TGF-beta 2) in breast cyst fluid. Erbas H; Lennard TW; Lai LC Anticancer Res; 1999; 19(4B):3077-82. PubMed ID: 10652596 [TBL] [Abstract][Full Text] [Related]
14. Influence of hormonal status of patients with cystic disease on the composition of cyst fluid and breast cancer risk. Budai B; Számel I; Sulyok Z; Németh M; Bak M; Kralovánszky J; Ottó S; Besznyák I; Purohit A; Parish DC; Reed MJ Anticancer Res; 2000; 20(5C):3879-86. PubMed ID: 11268470 [TBL] [Abstract][Full Text] [Related]
15. Mitogenic peptides in breast cyst fluid: relationship with intracystic electrolyte ratios. Lai LC; Ghatei MA; Takahashi K; Patel KV; Schrey MP; Ghilchik MW; Bloom SR; James VH Int J Cancer; 1990 Dec; 46(6):1014-6. PubMed ID: 2249889 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of ferritin, interleukin-6, interleukin-8 and tumor necrosis factor alpha in the differentiation of exudates and transudates in pleural effusions. Alexandrakis MG; Coulocheri SA; Bouros D; Eliopoulos GD Anticancer Res; 1999; 19(4C):3607-12. PubMed ID: 10629659 [TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor content of breast cyst fluids from women with breast cancer or proliferative disease of the breast. Torrisi R; Zanardi S; Pensa F; Valenti G; De Franchis V; Nicolo G; Barreca A; Minuto F; Boccardo F Breast Cancer Res Treat; 1995 Mar; 33(3):219-24. PubMed ID: 7749149 [TBL] [Abstract][Full Text] [Related]
18. [Epidermal growth factor behavior in breast cyst fluid. Differences as a function of the three existing types]. Vizoso F; Fueyo A; Díez MC; Ruibal A Rev Clin Esp; 1991 Sep; 189(4):194-5. PubMed ID: 1745812 [No Abstract] [Full Text] [Related]
19. Using biological measurements, can patients with benign breast disease who are at high risk for breast cancer be identified? Miller WR; Scott WN; Harris WH; Wang D Cancer Detect Prev; 1992; 16(2):99-106. PubMed ID: 1600527 [TBL] [Abstract][Full Text] [Related]
20. Electrolytes and trace elements in human breast cyst fluid. Sişman AR; Sis B; Canda T; Onvural B Biol Trace Elem Res; 2009 Apr; 128(1):18-30. PubMed ID: 18972071 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]